Afya Limited

NASDAQ:AFYA

Education & Training Services

Consumer Defensive
$10.30 -1.88%

-$0.26 today

Market cap
$941.96M
Beta
0.36
P/E (TTM)
8.3
EPS (TTM)
$8.45
Dividend yield
4.84%
52W Low $13.00High $18.50

Volume 0.13M

Average 0.10M

AFYA Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Afya LimitedNASDAQ: AFYA

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was R$0, compared with R$0 a year earlier. Trailing-twelve-month research & development was R$0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near R$0 or moves back toward the trailing-twelve-month quarterly average of R$0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
R$0— QoQ
Last fiscal yearDec 2025
R$0-100.0% YoY
LTMMar 2026
R$0-100.0% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

BRL · from the income statement

Latest · FY2025
0 BRL
Year-over-year change
-100.0%

Research & Development vs competitors

How AFYA compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -100.0% is the lowest of 2, against a peer median of +7.4%.
  • Research & development amounts to 0.0% of revenue for AFYA, versus a peer median of 8.4%.
AFYA Competitors
Research & Development for AFYA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSTMHealthStream, Inc.LTM Mar 2026$52.54M USD+7.4%+4.8%16.9%
AFYAAfya LimitedLTM Mar 2026R$0 BRL-100.0%—0.0%
WLYJohn Wiley & Sons, Inc.LTM Jul 2026$0 USD——0.0%
Peer median (excluding AFYA) —+7.4%+4.8%8.4%

Competitors are the stored peer set for AFYA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.72B2.33B2.88B3.3B3.62B
Cost of Revenue652.3M859.55M1.11B1.22B1.29B
Gross Profit1.07B1.47B1.77B2.09B2.34B
Gross Margin62.1%63.1%61.4%63.2%64.5%
Research & Development09.44M21.5M20.09M0
Selling, General & Admin622.62M798.15M1.01B1.07B1.15B
Operating Expenses626.18M805.58M999.04M1.08B1.15B
Depreciation & Amortization154.22M211.94M289.51M204.12M0
EBITDA603.33M929.03M1.11B1.22B1.34B
EBITDA Margin35.1%39.9%38.4%36.9%36.9%
Operating Income440.9M664.1M767.06M1.01B1.19B
Operating Margin25.6%28.5%26.7%30.6%32.8%
Interest Income23.04M27.2M107.12M43.42M0
Interest Expense175.65M288.65M386.3M366.35M493.78M
Other Income / Expenses(167.43M)(235.67M)(337.48M)(335.72M)(345.34M)
Income Before Tax273.46M428.43M429.58M676.39M844.03M
Pre-Tax Margin15.9%18.4%14.9%20.5%23.3%
Income Tax Expense31.18M35.68M24.17M27.47M90.68M
Net Income223.33M373.57M386.32M631.51M737.68M
Net Margin13.0%16.0%13.4%19.1%20.4%
EPS (Basic)2.394.154.277.018.16
EPS (Diluted)2.374.154.276.938.11
Weighted Avg Shares93.29M89.94M90.47M90.12M90.48M
Weighted Avg Shares (Diluted)94.1M89.94M90.54M91.15M91.27M

Afya Limited

NASDAQ:AFYA

Intrinsic Alpha fair value

Locked

Current Price

$10.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.